Who is sponsoring NCT04205201?

NCT04205201 is sponsored by Chittagong Medical College.

What drugs are being tested in NCT04205201?

Interventions in NCT04205201: Drugs, Investigational.

Is NCT04205201 still recruiting?

NCT04205201 is currently completed. Last updated 26 December 2019.

Last reviewed 2019-12-26 · How we verify

NCT04205201

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effectiveness of Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma

Completed Phase 2 Last updated 26 December 2019

What this trial tests

Phase 2 trial testing Drugs, Investigational in To See the Safety and Efficacy of the Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma Patients in 80 participants. Completed in 5 October 2019.

Timeline

25 June 2018

Primary endpoint
24 September 2019

5 October 2019

Quick facts

Lead sponsor	Chittagong Medical College
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	basic science
Enrollment	80
Start date	25 June 2018
Primary completion	24 September 2019
Estimated completion	5 October 2019
Sites	2 locations across Bangladesh

Drugs / interventions tested

Drugs, Investigational — full drug profile →

Conditions studied

To See the Safety and Efficacy of the Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma Patients — all drugs for To See the Safety and Efficacy of the Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma Patients →

Sponsor

Chittagong Medical College

Who can join

Adults 18 to 90, any sex, with To See the Safety and Efficacy of the Topical Latanoprost Compared With Topical Brimonidine in the Treatment of the Primary Open Angle Glaucoma Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Outpatient department of cmch, ceitc,cimch POAG patients enrolled for the study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Chittagong Medical College trials

Trials by the same sponsor.

NCT07526324 — Difelikefalin for Itching in Hemodialysis Patients With Chronic Kidney Disease · NA · not yet recruiting
NCT07262723 — Levosimendan in Acute Decompensated Heart Failure · Phase 2, PHASE3 · not yet recruiting
NCT06502288 — Evaluation of Antibiotic Administration Following Tooth Extraction · NA · not yet recruiting
NCT06918405 — Efficacy and Safety of Tirzepatide for Weight Management · Phase 3 · active not recruiting
NCT06847139 — Effect of Zinc Supplementation on Hyperhomocysteinemia Compared to Folic Acid in CKD Patient on Hemodialysis · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04205201 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chittagong Medical College
Last refreshed: 26 December 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04205201.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing